AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11554438
Drug: Theophylline (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (375 mg)
Trial: 11554438
Drug: Theophylline (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (500 mg)
Trial: 3147048
Drug: Theophylline (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (all doses)
Trial: 9755997
Drug: Omeprazole (PPI)
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole (PPI) administered through a jejunal tube after PPPD
Trial: 9755997
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution administered through a jejunal tube (Control group)
Trial: 3280316
Drug: Intravenous amiodarone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous amiodarone 5 mg kg‐1 with Tween 80 (A)
Trial: 3280316
Drug: Intravenous amiodarone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous amiodarone 5 mg kg‐1 without Tween 80 (N)
Trial: 29797913
Drug: Acupuncture combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture combined with western medication (dehydration and nutritional nerve treatment), treatment given once daily for 6 times per course, with 4 courses total.
Trial: 29797913
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication (dehydration and nutritional nerve treatment) alone.
Trial: 22917636
Drug: Arm 2
RxNorm normalized name: Surgitube Arm 2 5/8x50"
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm 2 (bisacodyl the day before and 2-L polyethylene glycol with citrates and simethicone on the day of colonoscopy)
Trial: 22917636
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (split-dose of 4-L polyethylene glycol)
Trial: 22917636
Drug: Arm 1
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Arm 1 (bisacodyl and 2-L polyethylene glycol with citrates and simethicone the day before)
Trial: 18403671
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg of salbutamol aerosol with a spacer device for bronchodilation
Trial: 15684169
Drug: Metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 10 mg, 3 times a day for 10 days
Trial: 12604505
Drug: Sodium lactate
RxNorm normalized name: Sodium Lactate
DrugBank: Lactic acid (DB04398)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium lactate infusion (60 micromol x kg(‐1) x min(‐1))
Trial: 12604505
Drug: Isomolar sodium
RxNorm normalized name: Watersoluble, nephrotropic, high osmolar X-ray contrast media
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isomolar sodium bicarbonate infusion
Trial: 10535525
Drug: Desferrioxamine (DFO)
RxNorm normalized name: DFO
DrugBank: Deferoxamine (DB00746)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desferrioxamine (DFO) infusion
Trial: 10535525
Drug: No DFO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No DFO infusion
Trial: 1768540
Drug: Paravertebral bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paravertebral bupivacaine (PVB) infusion
Trial: 1768540
Drug: Paravertebral saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paravertebral saline (PVS) infusion
Trial: 462160
Drug: Corynebacterium parvum
RxNorm normalized name: Corynebacterium parvum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corynebacterium parvum intrapleurally as adjuvant therapy
Trial: 30360637
Drug: Wood smoke
RxNorm normalized name: Wood creosote
DrugBank: Wood creosote (DB13271)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wood smoke exposure (500 μg/cm3)
Trial: 23932139
Drug: Long-chain inulin
RxNorm normalized name: Inulin
DrugBank: Inulin (DB00638)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Long-chain inulin (20g/L) added to low-fat yogurt
Trial: 17403972
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy (CBT) guided self-care
Trial: 30935010
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of white bread and sour milk cheese (food)
Trial: 25530603
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (delayed partial treatment of school fees only)
Trial: 23400614
Drug: School-Based Asthma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: School-Based Asthma Therapy (SBAT) program - administration of 1 dose of preventive asthma medication at school by the school nurse each school day.
Trial: 19108788
Drug: Azithromycin 1%
RxNorm normalized name: AZITHROMYCIN 1% OPH SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 1% ophthalmic solution
Trial: 19108788
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Azithromycin and Moxifloxacin)
Trial: 17414766
Drug: 40 mL
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mL of contrast material (350 mg of Iodine per milliliter)
Trial: 17414766
Drug: 50 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mL of contrast material (350 mg of Iodine per milliliter)
Trial: 17414766
Drug: Contrast volume
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast volume > 0.9 mL/kg body weight
Trial: 15355127
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil 500 mg twice daily
Trial: 11436969
Drug: Azelastine nasal
RxNorm normalized name: azelastine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine nasal spray and eye drops
Trial: 9752515
Drug: Initial chemotherapy
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial chemotherapy followed by locoregional treatment (Group B, n = 134)
Trial: 7826821
Drug: Quinine sulphate
RxNorm normalized name: Quinine sulphate
DrugBank: Quinine (DB00468)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quinine sulphate 600 mg
Trial: 3288172
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with Biofeedback (BFB) and FES
Trial: 29992264
Drug: Standardized classification
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized classification and framework for reporting medication non-adherence
Trial: 23086792
Drug: Transendocardial injection
RxNorm normalized name: ALCOHOL 80 mL in 100 mL TRANSENDOCARDIAL LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transendocardial injection of bone marrow-derived mononuclear cells (BMC)
Trial: 19175512
Drug: Insuflon (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insuflon (subcutaneous injection port)
Trial: 15860712
Drug: 9 g
RxNorm normalized name: Publix Pen Needle 29 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9 g PUFA daily
Trial: 9661647
Drug: iv arginine
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: iv arginine infusion (30 g) over 30 min
Trial: 9661647
Drug: oral L-dopa
RxNorm normalized name: α-methyl-L-dopa
DrugBank: Methyldopa (DB00968)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: oral L-dopa (500 mg)
Trial: 8136670
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of diuretics
Trial: 8136670
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (continued diuretic use)
Trial: 31254130
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A at the recommended dietary allowance (400 μg retinol activity equivalents/day)
Trial: 31254130
Drug: Maize enhanced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maize enhanced with β-carotene (2.86 mg/day)
Trial: 10743869
Drug: Group no.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group no. 1 (substituted toothbrush monthly)
Trial: 3905054
Drug: 324 mg
RxNorm normalized name: aspirin 324 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 324 mg of aspirin daily for 12 weeks
Trial: 3905054
Drug: heparin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: heparin therapy
Trial: 3905054
Drug: nitrates, beta-blockers,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nitrates, beta-blockers, calcium blockers, fibrinolytic therapy, and coronary angioplasty
Trial: 27151322
Drug: Flaxseed supplementation
RxNorm normalized name: FLAXSEED
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed supplementation (30-g brown milled flaxseed daily)
Trial: 24075240
Drug: Tears Again™
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tears Again™ liposome spray
Trial: 24075240
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of hypromellose drops and Tears Again™ liposome spray
Trial: 15920184
Drug: IV dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IV dexamethasone 0.25 mg/kg (D 0.25)
Trial: 15920184
Drug: IV dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IV dexamethasone 0.5 mg/kg (D 0.5)
Trial: 15920184
Drug: IV dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IV dexamethasone 1.0 mg/kg (D 1)
Trial: 14519792
Drug: Sterol ester
RxNorm normalized name: lanosterol esters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterol ester group (n = 28) consuming croissants and magdalenas enriched with sterol esters (3.2 g/d) for 8 weeks
Trial: 8793613
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg promethazine
Trial: 11051308
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg promethazine
Trial: 1418048
Drug: Terfenadine (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine (oral therapeutic doses)
Trial: 6747018
Drug: Methyldopa (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa (500 to 2000 mg/day)
Trial: 6747018
Drug: Propranolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80 to 320 mg/day)
Trial: 25440375
Drug: Curcuminoids (C3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcuminoids (C3 complex®); 1000 mg/day; n=50
Trial: 17432676
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (group A)
Trial: 17432676
Drug: Integrated Chinese
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated Chinese and Western medicine (group B)
Trial: 11916918
Drug: Blood letting
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood letting (three phlebotomies of 500 ml at 2-week intervals)
Trial: 10972349
Drug: Mineral supplementation
RxNorm normalized name: Mineral Oil
DrugBank: Mineral oil (DB11057)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mineral supplementation and vitamin D dose of 1000 IU/day
Trial: 10972349
Drug: Lower dose
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dose of vitamin D (500 IU/day)
Trial: 9365972
Drug: Atropine 0.02
RxNorm normalized name: ATROPINE 0.025/DIFENOXIN 1MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 0.02 mg.kg‐1
Trial: 1540020
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with RA not receiving drugs or receiving only NSAIDs
Trial: 1540020
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with RA receiving second line treatment in addition to NSAIDs
Trial: 3548209
Drug: Intravenous oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous oxytocin (Group A)
Trial: 3548209
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg PGE2 as a vaginal suppository (Group B)
Trial: 19875087
Drug: Pegaptanib 0.3
RxNorm normalized name: PEGAPTANIB 0.3MG/0.09ML INTRAOCULAR SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegaptanib 0.3 mg
Trial: 19875087
Drug: Pegaptanib 1
RxNorm normalized name: pegaptanib
DrugBank: Pegaptanib (DB04895)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pegaptanib 1 mg
Trial: 11939381
Drug: Standard support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard support from the community drug team (CDT)
Trial: 10516703
Drug: Atovaquone (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atovaquone (1500 mg daily from transplant day -5 to day -1, then 3 days per week until day +100)
Trial: 10516703
Drug: TMP/SMX (160/800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMP/SMX (160/800 mg daily from transplant day -5 to day -1, then 3 days per week until day +100)
Trial: 7726804
Drug: Behavioural group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioural group treatment
Trial: 2402122
Drug: 5% NaCl
RxNorm normalized name: LVP solution Dextrose 5% with 0.45% NaCl intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% NaCl infusion (6 mEq per kg body wt for 120 minutes)
Trial: 2402122
Drug: 2.5% NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% NaCl infusion (6 mEq per kg body wt for 120 minutes)
Trial: 2402122
Drug: 5% NaCl
RxNorm normalized name: LVP solution Dextrose 5% with 0.45% NaCl intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% NaCl infusion
Trial: 2402122
Drug: Desoxycorticosterone acetate
RxNorm normalized name: desoxycorticosterone acetate
DrugBank: Desoxycorticosterone acetate (DB06780)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desoxycorticosterone acetate (DOCA; 20 mg i.m. for three days) before saline (5%) infusion
Trial: 31997794
Drug: Autologous platelet-rich
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous platelet-rich plasma therapy with total contact casting (Group A)
Trial: 30940833
Drug: FOS at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOS at 2.5 g/day
Trial: 30940833
Drug: FOS at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOS at 5 g/day
Trial: 30940833
Drug: FOS at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOS at 10 g/day
Trial: 30940833
Drug: Placebo (Maltodextrin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (Maltodextrin 10 g/day)
Trial: 30940833
Drug: FOS (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOS (all doses)
Trial: 27910708
Drug: Myo-inositol (2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myo-inositol (2 g twice a day)
Trial: 27910708
Drug: Myo-inositol (2 g/d)
RxNorm normalized name: myo-inositol
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Myo-inositol (2 g/d) plus melatonin (3 g/d before sleeping)
Trial: 22448804
Drug: Adjunctive emotion
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjunctive emotion regulation group therapy (ERGT) for 14 weeks
Trial: 17206289
Drug: Placebo (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (100 ml normal saline infused before and during cardiopulmonary bypass)
Trial: 11555157
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with levamisole plus Chinese medicinal herbs
Trial: 7923458
Drug: Nifedipine 30
RxNorm normalized name: nifedipine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 30 to 90 mg/day
Trial: 7923458
Drug: Methyldopa 750
RxNorm normalized name: Methyldopa
DrugBank: Methyldopa (DB00968)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methyldopa 750 to 2000 mg/day
Trial: 30130297
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream with information that it would reduce pain
Trial: 30130297
Drug: Natural history
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural history group receiving pain stimuli without any application of cream or manipulation of expectation
Trial: 23553549
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate infusion 150 mEq/L in 5% dextrose solution
Trial: 23553549
Drug: 0.9% sodium
RxNorm normalized name: LMD with 0.9% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% sodium chloride 154 mEq/L infusion
Trial: 29910040
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate infusion
Trial: 23553549
Drug: Sodium chloride
RxNorm normalized name: Sodium Chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium chloride infusion
Trial: 20090541
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg kg(‐1) hydroxyzine hydrochloride suspension (Atarax) 1 h preoperatively (group I, n=15)
Trial: 20090541
Drug: 0.7 mg
RxNorm normalized name: naloxone 0.7 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.7 mg kg(‐1) midazolam (Dormicum) 15 min preoperatively (group II, n=15)
Trial: 20090541
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg kg(‐1) ketamine (Ketalar) with 0.25 mg kg(‐1) midazolam (Dormicum) 15 min preoperatively (group III, n=15)
Trial: 20090541
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral premedication administration (group IV, controls, n=15)
Trial: 17180512
Drug: Chemoradiotherapy (CRT)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoradiotherapy (CRT) with weekly carboplatin or low daily dose of cisplatin
Trial: 14649345
Drug: Adenosine 80
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenosine 80 microg kg min infusion
Trial: 14649345
Drug: Saline (control)
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline (control) infusion
Trial: 6487508
Drug: Nebulised salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulised salbutamol (conventional therapeutic doses)
Trial: 25198487
Drug: No music
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No music therapy (Control)
Trial: 27442130
Drug: Topical bromfenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical bromfenac
Trial: 12459926
Drug: Risperidone 0.25
RxNorm normalized name: risperidone 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 0.25 mg
Trial: 12459926
Drug: Risperidone 0.5
RxNorm normalized name: risperidone 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 0.5 mg
Trial: 10514777
Drug: Propofol with
RxNorm normalized name: propofol with medium chain triglycerides 10 mg/mL intravenous emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol with 20 mg of lidocaine
Trial: 10514777
Drug: Propofol with
RxNorm normalized name: propofol with medium chain triglycerides 10 mg/mL intravenous emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol with 40 mg of lidocaine
Trial: 1932611
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of 5 mg benzydamine
Trial: 1932611
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of benzydamine
Trial: 1932611
Drug: Dermal cream
RxNorm normalized name: PLO Transdermal Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermal cream application of benzydamine
Trial: 6588267
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training (3 to 5 times weekly for a mean of 12 +/- 4 months)
Trial: 29231343
Drug: Nilestriol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nilestriol (1 mg once a day) combined with oryzanol (20 mg three times per day)
Trial: 24169335
Drug: Glycyrrhizin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycyrrhizin (25 mg/kg)
Trial: 24169335
Drug: Glycyrrhizin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycyrrhizin (50 mg/kg)
Trial: 24169335
Drug: Glycyrrhizin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycyrrhizin (75 mg/kg)